• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Alveolar injury and regeneration following deletion of ABCA3.ABCA3 缺失后肺泡损伤和再生。
JCI Insight. 2017 Dec 21;2(24):97381. doi: 10.1172/jci.insight.97381.
2
ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol.小鼠中ABCA3失活会导致呼吸衰竭、肺表面活性物质丧失以及肺磷脂酰甘油耗竭。
J Lipid Res. 2007 Mar;48(3):621-32. doi: 10.1194/jlr.M600449-JLR200. Epub 2006 Dec 1.
3
Aberrant lung remodeling in a mouse model of surfactant dysregulation induced by modulation of the Abca3 gene.通过调控Abca3基因诱导的表面活性剂失调小鼠模型中的异常肺重塑。
Ann Anat. 2017 Mar;210:135-146. doi: 10.1016/j.aanat.2016.11.015. Epub 2016 Dec 26.
4
Conditional deletion of Abca3 in alveolar type II cells alters surfactant homeostasis in newborn and adult mice.肺泡 II 型细胞中 Abca3 的条件性缺失改变了新生和成年小鼠的表面活性物质动态平衡。
Am J Physiol Lung Cell Mol Physiol. 2010 May;298(5):L646-59. doi: 10.1152/ajplung.00409.2009. Epub 2010 Feb 26.
5
Ultrastructural and molecular analysis in fatal neonatal interstitial pneumonia caused by a novel ABCA3 mutation.由一种新型ABCA3突变引起的致命性新生儿间质性肺炎的超微结构和分子分析
Mod Pathol. 2007 Oct;20(10):1009-18. doi: 10.1038/modpathol.3800928. Epub 2007 Jul 27.
6
ABCA3 as a lipid transporter in pulmonary surfactant biogenesis.ABCA3作为肺表面活性物质生物合成中的脂质转运蛋白。
J Biol Chem. 2007 Mar 30;282(13):9628-9634. doi: 10.1074/jbc.M611767200. Epub 2007 Jan 30.
7
ABCA3 gene mutations in newborns with fatal surfactant deficiency.患有致命性表面活性物质缺乏症的新生儿中的ABCA3基因突变。
N Engl J Med. 2004 Mar 25;350(13):1296-303. doi: 10.1056/NEJMoa032178.
8
Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency.足月遗传性ABCA3缺乏婴儿肺表面活性物质系统的改变。
Am J Respir Crit Care Med. 2006 Sep 1;174(5):571-80. doi: 10.1164/rccm.200509-1535OC. Epub 2006 May 25.
9
ABCA3 is critical for lamellar body biogenesis in vivo.ABCA3对体内板层小体的生物合成至关重要。
J Biol Chem. 2007 Aug 17;282(33):23811-7. doi: 10.1074/jbc.M703927200. Epub 2007 May 31.
10
STAT3 regulates ABCA3 expression and influences lamellar body formation in alveolar type II cells.信号转导和转录激活因子3(STAT3)调节肺泡II型细胞中ATP结合盒转运体A3(ABCA3)的表达,并影响板层小体的形成。
Am J Respir Cell Mol Biol. 2008 May;38(5):551-8. doi: 10.1165/rcmb.2007-0311OC. Epub 2007 Dec 20.

引用本文的文献

1
Lentiviral-mediated gene complementation rescues pathogenic variants.慢病毒介导的基因互补可挽救致病变体。
bioRxiv. 2025 Aug 30:2025.08.29.673150. doi: 10.1101/2025.08.29.673150.
2
THERAPIES FOR NEONATAL DISEASES OF THE SURFACTANT SYSTEM.用于治疗新生儿表面活性物质系统疾病的疗法。
Trans Am Clin Climatol Assoc. 2025;135:119-129.
3
Novel Compound Heterozygous Mutation of the Gene in a Patient with Neonatal-Onset Interstitial Lung Disease.一名新生儿期起病的间质性肺疾病患者中该基因的新型复合杂合突变
J Clin Med. 2025 May 25;14(11):3704. doi: 10.3390/jcm14113704.
4
Alveolar epithelial paxillin in postnatal lung alveolar development.出生后肺肺泡发育中的肺泡上皮桩蛋白
Biol Open. 2025 Mar 15;14(3). doi: 10.1242/bio.061939. Epub 2025 Mar 20.
5
PBAE-PEG-based lipid nanoparticles for lung cell-specific gene delivery.基于聚(β-氨基酯)-聚乙二醇的脂质纳米颗粒用于肺细胞特异性基因递送。
Mol Ther. 2025 Mar 5;33(3):1154-1165. doi: 10.1016/j.ymthe.2025.01.037. Epub 2025 Jan 25.
6
Cell Population-resolved Multiomics Atlas of the Developing Lung.发育中肺脏的细胞群体解析多组学图谱
Am J Respir Cell Mol Biol. 2025 May;72(5):484-495. doi: 10.1165/rcmb.2024-0105OC.
7
Alveolar Organoids in Lung Disease Modeling.肺泡类器官在肺部疾病建模中的应用。
Biomolecules. 2024 Jan 16;14(1):115. doi: 10.3390/biom14010115.
8
Human pluripotent stem cell modeling of alveolar type 2 cell dysfunction caused by ABCA3 mutations.由ABCA3突变引起的2型肺泡细胞功能障碍的人类多能干细胞建模
J Clin Invest. 2024 Jan 16;134(2):e164274. doi: 10.1172/JCI164274.
9
Towards personalized therapies for genetic disorders of surfactant dysfunction.面向表面活性剂功能障碍遗传疾病的个体化治疗。
Semin Fetal Neonatal Med. 2023 Dec;28(6):101500. doi: 10.1016/j.siny.2023.101500. Epub 2023 Nov 22.
10
An integrated single-cell transcriptomic dataset for non-small cell lung cancer.非小细胞肺癌的综合单细胞转录组数据集。
Sci Data. 2023 Mar 27;10(1):167. doi: 10.1038/s41597-023-02074-6.

本文引用的文献

1
Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span.单核细胞来源的肺泡巨噬细胞驱动肺纤维化,并在整个生命周期中持续存在于肺中。
J Exp Med. 2017 Aug 7;214(8):2387-2404. doi: 10.1084/jem.20162152. Epub 2017 Jul 10.
2
Recruited Monocytes and Type 2 Immunity Promote Lung Regeneration following Pneumonectomy.募集的单核细胞和2型免疫促进肺切除术后的肺再生。
Cell Stem Cell. 2017 Jul 6;21(1):120-134.e7. doi: 10.1016/j.stem.2017.03.024. Epub 2017 May 11.
3
Outcomes of Lung Transplantation for Infants and Children with Genetic Disorders of Surfactant Metabolism.患有表面活性物质代谢遗传疾病的婴幼儿肺移植结果。
J Pediatr. 2017 May;184:157-164.e2. doi: 10.1016/j.jpeds.2017.01.017. Epub 2017 Feb 16.
4
Lipidomics reveals dramatic lipid compositional changes in the maturing postnatal lung.脂质组学揭示了产后肺部成熟过程中脂质组成的显著变化。
Sci Rep. 2017 Feb 1;7:40555. doi: 10.1038/srep40555.
5
Lung disease caused by mutations.由 突变引起的肺部疾病。
Thorax. 2017 Mar;72(3):213-220. doi: 10.1136/thoraxjnl-2016-208649. Epub 2016 Aug 11.
6
Functional Characterization of ATP-Binding Cassette Transporter A3 Mutations from Infants with Respiratory Distress Syndrome.患有呼吸窘迫综合征婴儿的ATP结合盒转运蛋白A3突变的功能特性
Am J Respir Cell Mol Biol. 2016 Nov;55(5):716-721. doi: 10.1165/rcmb.2016-0008OC.
7
Macrophage-epithelial interactions in pulmonary alveoli.肺泡中的巨噬细胞与上皮细胞相互作用。
Semin Immunopathol. 2016 Jul;38(4):461-9. doi: 10.1007/s00281-016-0569-x. Epub 2016 May 12.
8
Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS.通过隧道纳米管进行线粒体转移是间充质干细胞在急性呼吸窘迫综合征的体外和体内模型中增强巨噬细胞吞噬作用的重要机制。
Stem Cells. 2016 Aug;34(8):2210-23. doi: 10.1002/stem.2372. Epub 2016 Apr 29.
9
Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation.精氨酸酶1是一种控制2型炎症的固有淋巴细胞内在代谢检查点。
Nat Immunol. 2016 Jun;17(6):656-65. doi: 10.1038/ni.3421. Epub 2016 Apr 4.
10
Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function.血浆凝溶胶蛋白通过增强巨噬细胞一氧化氮合酶3(NOS3)的功能来改善肺部对肺炎的宿主防御。
Am J Physiol Lung Cell Mol Physiol. 2015 Jul 1;309(1):L11-6. doi: 10.1152/ajplung.00094.2015. Epub 2015 May 8.

ABCA3 缺失后肺泡损伤和再生。

Alveolar injury and regeneration following deletion of ABCA3.

机构信息

Perinatal Institute, Cincinnati Children's Hospital Medical Center, Division of Neonatology, Perinatal and Pulmonary Biology, Cincinnati, Ohio, USA.

Lawson Health Research Institute, Departments of Physiology and Pharmacology, Medicine, Western University, London, Ontario, Canada.

出版信息

JCI Insight. 2017 Dec 21;2(24):97381. doi: 10.1172/jci.insight.97381.

DOI:10.1172/jci.insight.97381
PMID:29263307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5752264/
Abstract

Adaptation to air breathing after birth is dependent upon the synthesis and secretion of pulmonary surfactant by alveolar type 2 (AT2) cells. Surfactant, a complex mixture of phospholipids and proteins, is secreted into the alveolus, where it reduces collapsing forces at the air-liquid interface to maintain lung volumes during the ventilatory cycle. ABCA3, an ATP-dependent Walker domain containing transport protein, is required for surfactant synthesis and lung function at birth. Mutations in ABCA3 cause severe surfactant deficiency and respiratory failure in newborn infants. We conditionally deleted the Abca3 gene in AT2 cells in the mature mouse lung. Loss of ABCA3 caused alveolar cell injury and respiratory failure. ABCA3-related lung dysfunction was associated with surfactant deficiency, inflammation, and alveolar-capillary leak. Extensive but incomplete deletion of ABCA3 caused alveolar injury and inflammation, and it initiated proliferation of progenitor cells, restoring ABCA3 expression, lung structure, and function. M2-like macrophages were recruited to sites of AT2 cell proliferation during the regenerative process and were present in lung tissue from patients with severe lung disease caused by mutations in ABCA3. The remarkable and selective regeneration of ABCA3-sufficient AT2 progenitor cells provides plausible approaches for future correction of ABCA3 and other genetic disorders associated with surfactant deficiency and acute interstitial lung disease.

摘要

出生后对空气呼吸的适应依赖于肺泡 II 型 (AT2) 细胞合成和分泌肺表面活性剂。表面活性剂是一种复杂的磷脂和蛋白质混合物,分泌到肺泡中,在那里它可以降低气液界面的塌陷力,以维持通气周期中的肺容积。ABCA3 是一种依赖 ATP 的 Walker 结构域包含转运蛋白,是表面活性剂合成和出生时肺功能所必需的。ABCA3 突变导致新生儿严重的表面活性剂缺乏和呼吸衰竭。我们在成熟的小鼠肺中条件性地敲除了 AT2 细胞中的 Abca3 基因。ABCA3 的缺失导致肺泡细胞损伤和呼吸衰竭。ABCA3 相关的肺功能障碍与表面活性剂缺乏、炎症和肺泡毛细血管渗漏有关。ABCA3 的广泛但不完全缺失导致了肺泡损伤和炎症,并启动了祖细胞的增殖,恢复了 ABCA3 的表达、肺结构和功能。M2 样巨噬细胞在 AT2 细胞增殖的部位被招募,并存在于由 ABCA3 突变引起的严重肺部疾病患者的肺组织中。ABCA3 充足的 AT2 祖细胞的显著和选择性再生为未来纠正 ABCA3 和其他与表面活性剂缺乏和急性间质性肺病相关的遗传疾病提供了合理的方法。